Cristal Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Cristal Therapeutics's estimated annual revenue is currently $1.6M per year.
- Cristal Therapeutics's estimated revenue per employee is $201,000
Employee Data
- Cristal Therapeutics has 8 Employees.
- Cristal Therapeutics grew their employee count by 0% last year.
Cristal Therapeutics's People
Name | Title | Email/Phone |
---|
Cristal Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is Cristal Therapeutics?
Cristal Therapeutics is a pharmaceutical company developing superior products based on its proprietary CriPec® platform. Cristal Therapeutics' mission is to improve the therapeutic performance of drugs resulting in commercial opportunities in various disease areas. The application of CriPec® potentially results in a better efficacy and enhanced tolerability due to an improved disposition. The first product that is independently being developed by Cristal Therapeutics is CriPec® docetaxel for the treatment of solid tumours. The company is founded in April 2011 and based in Maastricht, The Netherlands
keywords:N/AN/A
Total Funding
8
Number of Employees
$1.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.1M | 18 | 20% | N/A |
#2 | $5.3M | 28 | 47% | N/A |
#3 | $5M | 38 | -5% | N/A |
#4 | $5.2M | 41 | 46% | N/A |
#5 | $7.5M | 42 | 45% | N/A |